Who
In numbers
- Trades disclosed
- 33
- Buys
- 1
- Sells
- 5
- Bought
- $27K
- Sold
- $1.7M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Dec 2022
- Last trade
- 2 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 4 Sep 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $174K3,500 at $49.70 | filing |
| 2 Sep 2026filed 4 Sep 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $174K3,500 at $49.70 | filing |
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,392 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,392 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —14,248 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —10,860 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $100K14,248 at $7.04 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $119K10,860 at $10.95 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $441K14,248 at $30.98 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $336K10,860 at $30.98 | filing |
| 19 Jun 2025filed 20 Jun 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —14,150 at $0.00 | filing |
| 10 Jun 2025filed 11 Jun 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | $48K7,586 at $6.30 | filing |
| 10 Jun 2025filed 11 Jun 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | $28K4,000 at $7.04 | filing |
| 10 Jun 2025filed 11 Jun 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $48K7,586 at $6.30 | filing |
| 10 Jun 2025filed 11 Jun 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $28K4,000 at $7.04 | filing |
| 10 Jun 2025filed 11 Jun 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $289K26,931 at $10.72 | filing |
News
Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)AXGN · tickerreport.com · 21 Oct 2026Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Joseph A. Tyndall; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.